In Vitro Evaluation of No-Carrier-Added Radiolabeled Cisplatin ([189, 191Pt]cisplatin) Emitting Auger Electrons

نویسندگان

چکیده

Due to their short-range (2–500 nm), Auger electrons (Auger e−) have the potential induce nano-scale physiochemical damage biomolecules. Although DNA is primary target of e−, it remains challenging maximize interaction between e− and DNA. To assess DNA-damaging effect released as close possible without chemical damage, we radio-synthesized no-carrier-added (n.c.a.) [189, 191Pt]cisplatin evaluated both its in vitro properties effect. Cellular uptake, intracellular distribution, binding were investigated, double-strand breaks (DSBs) by immunofluorescence staining γH2AX gel electrophoresis plasmid Approximately 20% radio-Pt was a nucleus, about 2% intra-nucleus bound DNA, although uptake n.c.a. radio-cisplatin low (0.6% incubated dose after 25-h incubation), resulting frequency cells with foci (1%). Nevertheless, some treated had aggregates unlike non-radioactive cisplatin. These findings suggest causes severe DSBs release very carriers. Efficient radio-drug delivery necessary for successful clinical application e−.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Evaluation of DNA damage in a Her2+ cell line induced by an Auger-emitting immunoconjugate

Introduction: Auger electron based radioimmunotherapy (RIT) using 111In-DOTA-trastuzumab (111In-DOTA-antiHer2) feasibility was studied in vitro on a HER2/neu positive cell line, SkBr3. Methods:111In-DOTA-antiHer2 was prepared according to the optimized conditions followed by quality control tests including radioch...

متن کامل

Evaluation of cellular S-value of auger electrons emitting 111In radionuclide by Geant4 and its comparison with MCNP5 Monte Carlo codes and MIRD published data

Introduction: Now day Ionizing radiation has found increasing applications in cancer treatment. However, in the treatment different kinds and size of tumors especially metastatic and small size tumors, conventional methods of external radiation therapy are not common. In radionuclide therapy, the use of monoclonal antibodies has made it possible to achieve maximum dose to small size tumor and m...

متن کامل

Targetry for cyclotron production of no-carrier-added cadmium-109 from natAg(p,n)109Cd reaction

Background: Solid targets that consist of powder and electrodeposited targets are used commonly to produce radionuclides by accelerators. Since silver is easily electrodeposited in cyanide baths and has a very excellent thermal conductivity, the electrodeposited target is preferable to produce 109Cd. To avoid cracking or peeling of the target during bombardment, it should have a level surface a...

متن کامل

Production of no-carrier-added Ho-166 for targeted therapy purposes

Introduction:Holmium-166 radionuclide is one of the most effective radionuclides used for targeted therapy with theranostic properties. One method to produce this radioisotope is via the decay of its parent (indirect method). In this study applicability of extraction chromatography (EXC) for separation of no carrier added 166Ho from neutron-irradiated natura...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: International Journal of Molecular Sciences

سال: 2021

ISSN: ['1661-6596', '1422-0067']

DOI: https://doi.org/10.3390/ijms22094622